CAH 8-K: Guidance raise

Cardinal Health

Filed with the SEC on · accession 0000721371-26-000042

CAH filed a 8-K (current report) with the SEC on Nov 5, 2026. Cardinal Health reported Q1 FY2027 revenue of $67.5 billion (up 5% YoY) and non-GAAP diluted EPS of $3.26 (up 28% YoY), and raised its full-year FY2027 non-GAAP EPS guidance to $12.80-$13.00 from $12.40-$12.60. The stock moved +2.2% by the first close after the filing.

Summary of the filing

Cardinal Health reported Q1 FY2027 revenue of $67.5 billion (up 5% YoY) and non-GAAP diluted EPS of $3.26 (up 28% YoY), and raised its full-year FY2027 non-GAAP EPS guidance to $12.80-$13.00 from $12.40-$12.60. The company also completed a $500 million share repurchase program and announced a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.

Key details

Q1 FY2027 revenue$67.5B
Q1 FY2027 GAAP diluted EPS$2
Q1 FY2027 non-GAAP diluted EPS$3
FY2027 non-GAAP EPS guidance low$13
FY2027 non-GAAP EPS guidance high$13
Share repurchase program completed$500.0M
Additional uncommitted revolving credit facilities$1.0B
IssuerCardinal Health
Pharmaceutical distribution agreement renewalCVS Health
Acquisition target (diabetes health business)AdaptHealth
Research partnershipEli Lilly
CeoJason Hollar

How CAH stock reacted

Close before

$261.93

Nov 4, 2026

First close after

+2.25%

$267.82

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CAH, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CAH?

Click here

Frequently asked questions

What did CAH file with the SEC on Nov 5, 2026?

CAH filed a 8-K (Guidance raise). Cardinal Health reported Q1 FY2027 revenue of $67.5 billion (up 5% YoY) and non-GAAP diluted EPS of $3.26 (up 28% YoY), and raised its full-year FY2027 non-GAAP EPS guidance to $12.80-$13.00 from $12.40-$12.60. The company also completed a $500 million share repurchase program and announced a binding letter of intent to renew pharmaceutical distribution agreements with CVS Health.

What does a guidance raise mean for CAH stock?

Guidance is the company’s own forecast. Investors price stocks on the future, so a raise or cut often moves the stock more than the past quarter’s numbers.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CAH stock react to this filing?

CAH closed at $261.93 before the filing and $267.82 on Nov 5, 2026 (+2.25%).

Other CAH SEC filings

Get alerts when CAH files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days